These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33783940)
1. Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level. Li S; Lin L Environ Toxicol; 2021 Jul; 36(7):1457-1465. PubMed ID: 33783940 [TBL] [Abstract][Full Text] [Related]
2. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. Ou H; Qian Y; Ma L Aging (Albany NY); 2023 Jul; 15(13):6100-6116. PubMed ID: 37432067 [TBL] [Abstract][Full Text] [Related]
3. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. Cui F; Luo P; Bai Y; Meng J Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957 [TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis. Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920 [TBL] [Abstract][Full Text] [Related]
5. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis. Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372 [TBL] [Abstract][Full Text] [Related]
6. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis. Dong B; Zhang F; Zhang W; Gao Y Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855 [TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis. Kong W; Li H; Xie L; Cui G; Gu W; Zhang H; Ma W; Zhou Y BMC Cancer; 2021 Sep; 21(1):1069. PubMed ID: 34592939 [TBL] [Abstract][Full Text] [Related]
9. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1. Cheng G; Li Y; Liu Z; Song X Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1. Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer. Zhang G; An X; Zhao H; Zhang Q; Zhao H Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833 [TBL] [Abstract][Full Text] [Related]
12. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis. Li D; Li Z; YanFei W; Wang Y; Shi J; Liu C; Qu L; Deng S; Xiong D J Tissue Eng Regen Med; 2022 Apr; 16(4):335-345. PubMed ID: 34921595 [TBL] [Abstract][Full Text] [Related]
13. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer. Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. Shen D; Li J; Tao K; Jiang Y Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845 [TBL] [Abstract][Full Text] [Related]
15. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6. Liu L; Chen Y; Li Q; Duan P J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821 [TBL] [Abstract][Full Text] [Related]
16. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Zhao X; Wang J; Zhu R; Zhang J; Zhang Y Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a. Chen Q; Wang M; Wu S Cell Cycle; 2020 May; 19(9):1059-1065. PubMed ID: 32255731 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis. Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway. Du LJ; Mao LJ; Jing RJ Biochem Biophys Res Commun; 2020 Dec; 533(3):565-572. PubMed ID: 32981678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]